United States Sen. Gary Peters has reintroduced bipartisan legislation to help prevent future infant formula shortages.

There were unforgiveable shortcomings in management, which included critical information not reaching senior officials as ...

The lawsuit accuses Abbott of creating products called “transition formulas,” “follow-on formulas,” “weaning formulas” and “toddler milks” to boost earnings as infant formula sales ...

A bipartisan effort in the U.S. Senate seeks to improve the safety of infant formula. Introduced by Sen. John Hoeven, R-ND, and Sen. Gary Peters, D-MI, ...

Abbott, a health care products conglomerate ... by the U.S. Food and Drug Administration (FDA). Yet unlike baby formula, the toddler milk products are not regulated by the FDA and are potentially ...

LANSING, Mich. — Sen. Gary Peters has reintroduced a bill designed to stop future infant formula shortages from happening. The bipartisan legislation was drafted after a nationwide shortage in 2022 ...

(Read the full complaint below.) Abbott loses $500 million baby formula verdict Why Abbott and Dexcom buried the hatchet in their glucose monitor patent fight Abbott tries to claw back $24.3 ...

ABBOTT PARK, Ill. (AP ... Research was also for earnings of $1.34 per share. The maker of infant formula, medical devices and drugs posted revenue of $10.97 billion in the period, missing ...

ABBOTT PARK, Ill. (AP) — ABBOTT PARK ... surveyed by Zacks Investment Research was also for earnings of $1.34 per share. The maker of infant formula, medical devices and drugs posted revenue of $10.97 ...